Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenon Pharmaceuticals

37.84
+0.22000.58%
Post-market: 37.840.00000.00%16:05 EDT
Volume:502.06K
Turnover:18.99M
Market Cap:2.89B
PE:-12.58
High:38.55
Open:37.65
Low:37.45
Close:37.62
Loading ...
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 19, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 27, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities